Anthony F. Shields - Concepedia

Author

Anthony F. Shields

The Barbara Ann Karmanos Cancer Institute ORCID

Also Known As

A F Shields, A Shields, A. F. Shields, A. Shields, A.F Shields, A.F. Shields, ANTHONY F SHIELDS, ANTHONY F. SHIELDS, Alisa J. Stephens Shields, Anthony F SHIELDS

768

Publications

19.2K

Citations

H-Index

167

Concepts

All Affiliations

The Barbara Ann Karmanos Cancer Institute Wayne State University Caris Life Sciences (United States)Georgetown University Georgetown University Medical Center

About

Anthony F. Shields is an author at The Barbara Ann Karmanos Cancer Institute specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	75	3.9K
2	Health Sciences	17	24	2.4K
3	Engineering	11	12	1.9K
4	Natural Sciences	7	7	649
5	Nursing	1	1	35

Anthony F. Shields

213

Publications

17.1K

Citations

H-Index

Page 1

	Year	Citations
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Anthony F. Shields, John R. Grierson, Bernhard M. Dohmen, Nature Medicine Positron Emission TomographyEngineeringOncologic ImagingMedical ImagingBiomedical Imaging	1998	1.2K
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer Axel Grothey, Alberto Sobrero, Anthony F. Shields, New England Journal of Medicine	2018	1.1K
Recommendations on the Use of <sup>18</sup>F-FDG PET in Oncology James Fletcher, Benjamin Djulbegović, Heloisa P. Soares, Journal of Nuclear Medicine	2008	1.1K
Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04 Michael J. O’Connell, Linda H. Colangelo, Robert W. Beart, Journal of Clinical Oncology	2014	438
Adenovirus Infections in Patients Undergoing Bone-Marrow Transplantation Anthony F. Shields, Robert C. Hackman, Kenneth H. Fife, New England Journal of Medicine	1985	423
Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry Bruce E. Hillner, Barry A. Siegel, Dawei Liu, Journal of Clinical Oncology	2008	373
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer Helen Lee, Anthony F. Shields, Barry A. Siegel, Clinical Cancer Research	2017	359
The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions Louis A. Penner, John F. Dovidio, Richard Gonzalez, Journal of Clinical Oncology	2016	337
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial Carmen J. Allegra, Greg Yothers, Michael J. O’Connell, JNCI Journal of the National Cancer Institute	2015	326
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313 Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip, Journal of Clinical Oncology	2019	314

Page 1